Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb
Fig.1: Coomassie staining of SDS-PAGE gel loaded with Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb (Abeomics Cat# 12-2003)
Roll over image to zoom in
Shipping Info:
Order now and get it on Wednesday July 03, 2024
Same day delivery FREE on San Diego area orders placed by 1.00 PM
| Amount : | 100 µg |
| Isotype : | IgG1 |
| Purification : | Purified from cell culture supernatant by affinity chromatography |
| Storage condition : | Store at -20°C to -80°C (Avoid repeated freezing and thawing). |
Tremfya or Guselkumab biosimilar is human immunoglobulin G1 lambda (IgG1lambda) monoclonal antibody, a member of the interleukin inhibitors that selectively block interleukin-23 p19. It usually is important in the treatment of Psoriasis. IL-23 is an inflammatory cytokine responsible for the induction of psoriatic plaque formation. It activates the CD4+ T-helper (Th17) cell pathway. Guselkumab biosimilar developed by Abeomics is for research use only and should not be used in diagnostic procedures.
ELISA 1:5000-10000, FACS 1:100
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
